In the midst of the unprecedented COVID-19 pandemic that had UC San Diego researchers racing to understand the complexities around the virus’s spread and to find ways to combat it, engineers and fabrication specialists at the Qualcomm Institute’s Prototyping Lab leapt into action.
What is the goal of the Return to Learn program? What role does testing play in preventing an outbreak? UC San Diego infectious disease modeler Natasha Martin addresses top questions from the campus community.
Cancer doesn’t stop because of a pandemic. People diagnosed with cancer must continue lifesaving treatment. Sometimes the only options are clinical trials. That is why, despite some modifications, UC San Diego Health has continued its cancer clinical trial enrollment.
An international team of researchers has developed a non-invasive blood test that can detect whether an individual has one of five common types of cancers, four years before the condition can be diagnosed with current methods.
Engineers have incorporated a new understanding of the impact of environmental factors on droplet spread into a mathematical model that can be used to predict the early spread of respiratory viruses including COVID-19, and the role of respiratory droplets in that spread.
Scientists have unraveled key mechanisms behind the mysteries of aging. They isolated two paths that cells travel during aging and engineered a new way to genetically program these aging routes. The researchers also identified a master circuit that guides the aging processes.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
